Literature DB >> 19966938

Microarray gene expression profiling using core biopsies of renal neoplasia.

Craig G Rogers, Jonathon A Ditlev, Min-Han Tan, Jun Sugimura, Chao-Nan Qian, Jeff Cooper, Brian Lane, Michael A Jewett, Richard J Kahnoski, Eric J Kort, Bin T Teh.   

Abstract

We investigate the feasibility of using microarray gene expression profiling technology to analyze core biopsies of renal tumors for classification of tumor histology. Core biopsies were obtained ex-vivo from 7 renal tumors-comprised of four histological subtypes-following radical nephrectomy using 18-gauge biopsy needles. RNA was isolated from these samples and, in the case of biopsy samples, amplified by in vitro transcription. Microarray analysis was then used to quantify the mRNA expression patterns in these samples relative to non-diseased renal tissue mRNA. Genes with significant variation across all non-biopsy tumor samples were identified, and the relationship between tumor and biopsy samples in terms of expression levels of these genes was then quantified in terms of Euclidean distance, and visualized by complete linkage clustering. Final pathologic assessment of kidney tumors demonstrated clear cell renal cell carcinoma (4), oncocytoma (1), angiomyolipoma (1) and adrenalcortical carcinoma (1). Five of the seven biopsy samples were most similar in terms of gene expression to the resected tumors from which they were derived in terms of Euclidean distance. All seven biopsies were assigned to the correct histological class by hierarchical clustering. We demonstrate the feasibility of gene expression profiling of core biopsies of renal tumors to classify tumor histology.

Entities:  

Keywords:  amplification; biopsy; cDNA microarray; gene expression profiling; kidney tumor

Year:  2009        PMID: 19966938      PMCID: PMC2776289     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  34 in total

1.  Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy.

Authors:  Arvind Vasudevan; Robert J Davies; Beverley A Shannon; Ronald J Cohen
Journal:  BJU Int       Date:  2006-05       Impact factor: 5.588

2.  Renal mass core biopsy: accuracy and impact on clinical management.

Authors:  Katherine E Maturen; Hanh V Nghiem; Elaine M Caoili; Ellen G Higgins; J Stuart Wolf; David P Wood
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

3.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

4.  Accuracy of diagnosis by guided biopsy of renal mass lesions classified indeterminate by imaging studies.

Authors:  F Richter; N G Kasabian; R J Irwin; R A Watson; E K Lang
Journal:  Urology       Date:  2000-03       Impact factor: 2.649

5.  Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up.

Authors:  Bhaskar Kumar Somani; Ghulam Nabi; Peter Thorpe; James N'Dow; Satchi Swami; Sam McClinton
Journal:  Eur Urol       Date:  2006-10-25       Impact factor: 20.096

6.  Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.

Authors:  Daniel A Barocas; Susan Mathew; Joseph J DelPizzo; E Darracott Vaughan; R Ernest Sosa; Ronnie G Fine; Mohamed Akhtar; Douglas S Scherr
Journal:  BJU Int       Date:  2006-12-01       Impact factor: 5.588

7.  Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis.

Authors:  D A Barocas; S M Rohan; J Kao; R D Gurevich; J J Del Pizzo; E D Vaughan; M Akhtar; Y-T Chen; D S Scherr
Journal:  J Urol       Date:  2006-11       Impact factor: 7.450

8.  The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.

Authors:  Beverley A Shannon; Ronald J Cohen; Hildemarie de Bruto; Robert J Davies
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

Review 9.  Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy.

Authors:  Alessandro Volpe; John R Kachura; William R Geddie; Andrew J Evans; Arash Gharajeh; Arthy Saravanan; Michael A S Jewett
Journal:  J Urol       Date:  2007-06-11       Impact factor: 7.450

10.  Percutaneous core biopsy for renal masses: indications, accuracy and results.

Authors:  Thierry Lebret; Jean Eudes Poulain; Vincent Molinie; Jean Marie Herve; Yves Denoux; Axel Guth; Antoine Scherrer; Henry Botto
Journal:  J Urol       Date:  2007-08-14       Impact factor: 7.450

View more
  2 in total

1.  The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.

Authors:  Jennifer Jones; Jaimin Bhatt; Jonathan Avery; Andreas Laupacis; Katherine Cowan; Naveen Basappa; Joan Basiuk; Christina Canil; Sohaib Al-Asaaed; Daniel Heng; Lori Wood; Dawn Stacey; Christian Kollmannsberger; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862

Review 2.  Heterogeneity and renal mass biopsy: a review of its role and reliability.

Authors:  Jeffrey J Tomaszewski; Robert G Uzzo; Marc C Smaldone
Journal:  Cancer Biol Med       Date:  2014-09       Impact factor: 4.248

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.